The Critical Amino Acids of a Nephritogenic Epitope on Human Goodpasture Autoantigen for Binding to HLA-DRB1*1501

Qiu-hua Gu,Xiao-yu Jia,Jian-nan Li,Fang-jin Chen,Zhao Cui,Ming-hui Zhao
DOI: https://doi.org/10.1016/j.molimm.2017.05.011
IF: 4.174
2017-01-01
Molecular Immunology
Abstract:Background: Anti-GBM disease is caused by autoimmunity to Goodpasture antigen on alpha 3(IV)NC1 and had strong associations with HLA-DRB1*1501. Previous studies identified alpha 3(127-148) (P14: TDIPPCPHGWISLWKGFSFIMF) as a T cell epitope. The present study was aimed to investigate the binding capacity of P14 to HLA-DRB1*1501 and the critical amino acids for this binding.Methods: A line of EBV-transformed human B cells homozygous for HLA-DRB1*1501 was used to detect the binding capacity of peptides to HLA-DRB1*1501 using flow cytometry analysis. P14 was sequentially truncated into 8 peptides with 15 amino acids to identify the core binding motif. A set of alanine substituted peptides of P14-2 was then synthesized to identify its critical residues for binding to HLA-DRB1*1501. The structure of HLA-DR2b-Peptide-TCR complex was constructed by modeling to analyze the interaction of each amino acids of P14-2 with the HLA-DR2b molecule.Results: P14 could bind to HLA-DRB1*1501 expressed on B cell surface. The N-terminus of P14 was the core binding motif and the truncated peptide P14-2 (DIPPCPHGWISLWKG) (128-142) had the strongest binding capacity. After sequential amino acid substitution, we found the binding capacity of P14-2 was completely lost by the substitution of cysteine (C) (132) and significantly decreased by the substitution of tryptophan (W) 136, lysine (K) (141), or glycine (G) (142), but still at a high level. The modeling showed that (C) (132) had a strong interaction with pocket 4 on the beta chain of DR2b. Thus, C-132, W (136), K-141, and G(142) were defined as the critical amino acid residues for the binding capacity of P14 to HLA-DRB1*1501.Conclusion: We identified alpha 13(128-142) (DIPPCPHGWISLWKG) as the core binding motif of P14 to HLA-DRB1*1501 molecule. And the critical amino acid residues for this binding were further defined as C-132, W (136), K (141), and G (142).
What problem does this paper attempt to address?